INTRODUCTION {#S1}
============

Hypertension is the most frequent primary diagnosis in the United States and affects 1 billion people worldwide. It is associated with numerous conditions including diabetes, renal morbidity, stroke and other cardiovascular events. Fortunately, the consequences of lowering blood pressure (BP) have equally dynamic effects, with a decline in the incidence of myocardial infarction of 20-25% and cerebral vascular events of 35-40% with proper treatment.[@B1] Still, patients frequently incorrectly assess actual risks, with up to 46% of hypertensive or diabetic patients overestimating their risks, and 23% unable to provide an estimation of their risk factors.[@B2]

National Guidelines[@B3] state that simple and ongoing intervention by a team of health professionals can significantly improve adherence to lifestyle modifications. Pharmacists' involvement as member of the health care team in drug monitoring has markedly reduced patient BP.[@B4]-[@B8] Pharmacists are one of the most accessible health care professionals, and as such are optimally positioned[@B9]-[@B12] to monitor drug therapy and self-monitoring practices[@B13], to support better clinical outcomes.[@B13],[@B15]

Although hypertension is often described as a silent disease, many patients actively manage their anti-hypertensive medications. In one sample of 623 patients with hypertension, one third self-initiated a reduction in dose or eliminated their hypertension medications.[@B16] These patients may have benefited from the support of a pharmacist's medication expertise. Pharmacists' contributions are not limited to drug information, but could also include disease education, encouragement of greater patient responsibility, use of drug compliance aids and implementation of BP monitoring programs as a part of a comprehensive approach to hypertension management.

In order to improve pharmacists' care for patients with hypertension, the patients' understanding of hypertension and self-monitoring practices need to be better understood. Three studies examined the knowledge of personal BP readings and target levels, as well as self-management techniques of patients with hypertension and/or diabetes in the community.[@B9],[@B17],[@B18] The data in all three studies were collected via patient self-report in response to direct questioning or self administered questionnaires in either a medical clinic or community pharmacy. Between 39-68% of patients were aware of their BP values, while only 20-30% of patients were able to recall their targeted BP.[@B9],[@B17],[@B18] Patient education on target BP and hypertension-associated health risks were found to be a significant predictor of self BP awareness and monitoring habits[@B9], indicating a need for pharmacists to take an increased role in patient--directed hypertension care.

In order to obtain a better understanding of patient perceptions of their BP levels, goals and monitoring practices in the community, we conducted a cross sectional survey of patients who were on medications to control hypertension and included an assessment of patients' self monitoring practices. Our methodology utilizes a face to face patient encounter which, similar to the study by Guirguis et al.[@B18], may allow for content clarification by the patient, hence improving reporting accuracy by patients.

This primary objective of this research is to describe the knowledge and self-monitoring practices of a sample of patients recruited in a community pharmacy. Specifically, we would determine: 1) the proportion of patients with hypertension who reported a BP target and level, 2) the proportion of patients at national targets for BP, and 3) patients' self-monitoring practices.

Secondary objectives address the relationships between patients': 1) evaluation of their BP control and knowledge of a BP level, 2) perceptions about their BP and self monitoring practices, and 3) knowledge of BP levels / targets and BP self-monitoring habits.

METHODS {#S2}
=======

Pharmacy students in their final year gathered data from a required exercise as part of their Ambulatory Pharmaceutical Care Clerkship in a one year period. The project was reviewed and approved by the University of Wisconsin-Madison Health Sciences Institutional Review Board.
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### Subjects {#S4}

Patients were recruited from the clerkship sites affiliated with the School of Pharmacy at the University of Wisconsin-Madison. These clerkship sites are community, chain, or clinic pharmacies. Approximately 120 student pharmacists recruited at least 5 and up to 10 patients. Student pharmacists were asked to select a convenience sample of patients who were on medication for hypertension. There were no material inducements.

### Data Collection {#S5}

Student pharmacists were trained on data collection and provided with written directions and an interview guide to ensure that information was gathered systematically. Pharmacy managers were asked to consent to data collection at their site. Student pharmacists approached patients on anti-hypertensive medications during regular pharmacy activities, asked patients to share their BP levels and target numbers, recorded information on the interview guide, and provided an information sheet and monitoring log on BP provided by the American Heart Association. They are titled: "What is High BP?" and "BP Tracker".[@B19],[@B20] These tools promote targets set by the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High BP (JNC 7).[@B1] After the interview was administered, pharmacy students asked patients for verbal consent to share their BP information data for research and provided patients with a written study information sheet. Students then transcribed data from the interview guide onto a secure online website. Students were asked to transcribe the data as patients reported it and include "DK" for Don't Know.

While students were encouraged to make recommendations to their patients and patients' other health care providers with patients' permission if the hypertension control was sub-optimal, this was not a required part of the assignment.

### Analysis {#S6}

All data were analyzed with SPSS version 13.0. An alpha of 0.05 was used to evaluate all statistical tests. Implausible levels or target numbers were coded as missing. For example, a BP level of "300/600" was coded as missing. Descriptive statistics were used to characterize the data from the interview guide including patients' self-reported knowledge of BP, treatment goals, and demographics. Patients' self-reported BP levels were compared to patients' self-reported clinical goals and targets in the JNC 7 to identify patients who are above targets.[@B1] Chi-square analysis was used to test secondary objectives about relationships between knowledge of BP and self-monitoring practices.

RESULTS {#S7}
=======

Data were gathered by students completing their community pharmacy clerkship at 39 sites in Wisconsin. 120 students approached 716 patients and of those 620 had time to talk and 449 patients consented to participate in the study (see [Figure 1](#F1){ref-type="fig"}). Only 2 patients were diabetic, which is lower than the expected prevalence of 5-10%. However in the prior year, students had approached patients regarding awareness of diabetes targets and thus patients with diabetes may have been passed over in the BP check. Thus, the data for the 2 patients with diabetes was removed, as an analysis of this subgroup would not be meaningful. Furthermore, 38 patients who received the BP check at least once before had their second BP check presented separately. There were no statistical differences between patient reports in the first and second BP checks (see Tables [1](#T1){ref-type="table"} to [3](#T3){ref-type="table"}).

###### 

Patient Reported Blood Pressure Target

  ------------------- ---------------- ------------------- ---- ---------
                      First BP Check   Second BP Check\*        
  Target              n                Percent             n    Percent
  120/80 mmHg         51               12.5                6    15.8
  130/80 mmHg         17               4.2                 2    5.3
  140/90 mmHg         33               8.1                 2    5.3
  Other               47               11.5                6    15.8
  Don't Know Target   244              59.7                22   57.9
  Missing             17               4.2                 0    0
  TOTAL               409              100%                38   100
  ------------------- ---------------- ------------------- ---- ---------

\* No statistical differences between first and second BP check

###### 

Patients at JNC 7 Guideline Targets

  ------------------------------- ---------------- -------------------------------------------- --------- --------------------------------
                                  First BP Check   Second BP Check[\*](#t2fn1){ref-type="fn"}             
  n                               Percent          N                                            Percent   
  At Target (≤140/90 mmHg)        206              69.4[†](#t2fn2){ref-type="fn"}               21        77.8[†](#t2fn2){ref-type="fn"}
  Not At Target (\>140/90 mmHg)   91               30.6[†](#t2fn2){ref-type="fn"}               6         22.2[†](#t2fn1){ref-type="fn"}
  Don't Know BP Level             98               24.0[‡](#t2fn3){ref-type="fn"}               9         23.7[‡](#t2fn3){ref-type="fn"}
  Missing                         14               3.4[‡](#t2fn3){ref-type="fn"}                2         5.3[‡](#t2fn3){ref-type="fn"}
  TOTAL                           409              \--                                          38        \--
  ------------------------------- ---------------- -------------------------------------------- --------- --------------------------------

No statistical differences between first and second BP check

Of those who know their BP level n=297; n=27

Of the total number surveyed n=409; n=38

###### 

Patients at Self-Reported Target

  ----------------------------- ---------------- ------------------- --------- ------
                                First BP Check   Second BP Check\*             
  n                             Percent          N                   Percent   
  At Self-Reported Target       49               12.0                7         18.4
  Not at Self-Reported Target   79               22.2                5         21.1
  Don't Know Target             258              60.6                23        55.3
  Missing                       23               5.1                 3         5.3
  TOTAL                         409              100%                38        100%
  ----------------------------- ---------------- ------------------- --------- ------

\* No statistical differences between first and second BP check.
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### Patient BP Knowledge and Self-Monitoring {#S9}

First, we assessed patient knowledge about their BP targets. Of the 148 first BP checks who reported a target: 34.5% of patients reported a target of 120/80 mmHg, 11.5% reported 130/80 mmHg, 22.3% reported 140/90 mmHg and 31.8% reported other reasonable values (see [Table 1](#T1){ref-type="table"}). At their second BP check, 26.4% responded with one of the three accepted targets (see [Table 1](#T1){ref-type="table"}).[@B1] Over three fourths of patients were able to report a BP level (see [Table 2](#T2){ref-type="table"}). JNC 7 BP guidelines current at the time of the study recommend treating hypertension to ≤140/90 mmHg (see [Table 2](#T2){ref-type="table"}).[@B1] Of the 128 people who reported a BP target and level, 38.3% met their goal ([Table 3](#T3){ref-type="table"}).

![Blood pressure project participation \* Insignificant diabetic population size](pharmpract-08-187-g001){#F1}

Patients were also asked to evaluate their BP as being 'high', 'low' or 'about right'. Most patients from both groups however, deemed themselves 'about right'; 65.5% of patients at their first BP check and 71.1% patients at the second BP check. About a quarter to a third felt their BP was 'high' (30.1% and 26.3% of those respectively). Finally, few patients reported having a 'low' BP (3.4% and 2.6% respectively).

Students also assessed the frequency of patients' home BP monitoring; 37.7% performed self monitoring at the first BP check, compared to 47.4% of those at their second BP check. Both groups had similar habits when it came to monthly BP monitoring-59.9% and 57.9% respectively.

### Relationships between Blood Pressure Knowledge and Monitoring {#S10}

The total sample of 447 BP checks was used for the secondary analysis as there were no differences between first and second BP checks in primary analyses. We found patient's evaluations of BP, ('about right', 'high' or 'low') was not related to patients' knowledge of a BP level (p=0.611).

For secondary objective 2, patients who monitored their BP at least monthly were less likely (p=0.02) to evaluate their BP as 'about right' (61.5% who monitor vs. 73.3% who do not monitor), and more likely to think that their BP was lower (4.9% vs. 1.2%, respectively) or higher (33.6% vs. 25.5%, respectively) than those who do not monitor. There was no relationship between evaluations of BP control and home monitoring (p=0.953).

For secondary objective 3, knowledge of a BP target and level was related to a patient's monthly self-monitoring practices (p=0.011 and p=0.001, respectively), as well as their home monitoring habits (p=0.0001 and p= 0.001, respectively). Those who monitored their BP at least monthly were more likely to know their target BP than those who did not (42.8% vs. 30.1%, respectively). Similarly, patients who monitored their BP at home also were more likely to know their target values than those who do not (50.0% vs. 30.2% respectively). This trend is also seen in patients who were able to report a BP levels, as those who monitor monthly were more likely to know their BP than those who did not monitor regularly (81.2% vs. 66.0%). This relationship is similar in those who monitored at home; 84.3% know their levels versus 69.4% of those who did not monitor at home.

DISCUSSION {#S11}
==========

Overall, patients identified through community pharmacies had limited knowledge about national BP goals and personal BP targets. Although many knew their BP levels, a poor awareness of target guidelines meant that they may be unable to interpret their risk. Similar to Guirguis et al.[@B18], three-quarters of patients could report a BP level, yet only 40% were aware of their target. Thus, 30% of patients may not be able to evaluate their progress. Only a quarter were able to report one of the three recognized JNC 7 target guidelines[@B1], and a second questioning of a smaller population of the same group only saw no improvement. However, these results are considerably higher than those found in a similar study by Lau et al., who reported that only 8.9% of a geriatric patient population knew of an acceptable target.[@B9] In contrast, Guirguis et al. reported that 35% of patients were able to provide a recognized target.[@B18] The discrepancies between these values may be attributed to the larger age demographic of our sample (ie. not restricted to geriatrics), as well as the exclusion of patients with diabetes. In analyzing patient's ability to identify targets, we could not to take into account the possibility that patients may have had physician-modified targets as a result of concurrent medical conditions.

Of those who reported a target, more than a third were at their target BP, which is comparable to results found by Whitley et al. (37% achieving goal)[@B17], and Guirguis et al (34.8% at goal).[@B18] This suggests that although patients are more inclined to know their personal BP levels, this knowledge can be without regard to knowledge of a target goal. Furthermore, the majority of patients surveyed (65.5% - 71.1%) had the perception that their BP levels were 'about right'. However these perceptions may not be indicative of actual BP levels and may place patients at risk of poor medication adherence.[@B16]

Patient evaluation of BP control (i.e., high, low, or about right) did not vary with knowledge of a BP level. This could have occurred for three reasons: firstly, patients may have only been provided with a global perception of their BP --high, low, or about right. Thus, remembering a BP level did not correlate with their ability to evaluate their BP. This knowledge may be sufficient to motivate activities to promote BP control; although it merits further study. Secondly, perceptions of BP control may be derived from factors other than BP levels. Patients may form perceptions of BP control based on their perceived physiological signs and symptoms of BP such as headache or dizziness. We were unable to determine if patients' perceptions reflected their true BP levels as we did not obtain an objective measure of BP. Third, this may also be indicative of low health literacy. It is estimated that 78% of people are unable "to obtain, process, and understand basic health and medication information and \[services\] needed to make appropriate health decisions".[@B21] Future research should consider a measure of health literacy to investigate the role of health literacy on patients' BP knowledge and assessment.

Despite these findings, patients who knew their BP level and/or target also were more likely to monitor their BP. We do not know which variable is the causative factor. This is similar to work by Lau et al., which demonstrated knowledge of target BP is an independent predictor of self monitoring.[@B9]

Further analysis found no differences between the data sets of the first and second BP check groups. This could be attributed to several possible reasons, the first being that the second group had a small sample size. Secondly, the study was not intended to have patients interviewed more than once and lastly, time between visits may have been insufficient for measurable change.
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### Implications for Practice {#S13}

Pharmacists may find that patients who monitor their BP monthly may be less inclined to have a complacent perception towards their hypertensive therapy. The data provided by monitoring may allow pharmacists to provide personalized care. There is also a role for pharmacists to screen patients with poorly managed hypertension through minimal interventions (ie. similar to our self-report survey) and promote self-monitoring to those who may be suitable. This study along with others before it[@B9],[@B17],[@B18], point to the knowledge gaps present in patients with chronic conditions. Pharmacists can remedy this by enhancing patient understanding of hypertension with the goal of improving medication adherence and patient health.

There is a need to investigate the relationship between patients' BP control evaluations (i.e., high, low, or about right) and their objective BP control. In practice, pharmacists may need to know if patients who perceive their BP to be 'about right' are correct in their assumption. Patients' perceptions of BP may influence their medication taking, BP monitoring and lifestyle.

### Limitations {#S14}

There are several limitations to our research. First, the use of convenience sampling may skew our results such that they are not generalizable to the larger hypertensive population. Students may also be predisposed to selecting patients that appear more approachable or receptive. Despite this, our selection strategy is reflective of current pharmacy practice. Second, a patient's social desirability and recall error likely affects the accuracy of their reported levels in self-reported data. Yet in light of this, one-third of patients still reported levels that were not on target. The advantage of self-report data is that it allows practitioners to identify the patient's understanding and provides insight on knowledge gaps. Furthermore, it allows for content clarification during a face-to-face interaction. Third, when analyzing the data, we did not take into account adjustment of individual BP targets that may have been as a result of other comorbidities. Consequently, more patients may have been 'at target', though this target may not be one that is recognized by JNC 7 guidelines.

CONCLUSIONS {#S15}
===========

In community pharmacies, 63% of patients were able to recall a BP Level and 37% reported a blood pressure target. Only 12% of patients met their self-reported target; while two thirds felt their BP was about right. Sixty percent of patients monitor their BP monthly, but less than 50% of patients practice home BP monitoring. This study along with others before identified knowledge gaps in patients with chronic conditions. Pharmacists can help to enhance patient understanding and promote increased self-management through regular BP monitoring.
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